Document Detail


Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
MedLine Citation:
PMID:  8301577     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present study compared the effects of two analogs of corticotropin-releasing factor (CRF), [D-Phe12,Nle21,38, C alpha MeLeu37]CRF12-41 (D-PheCRF12-41) and alpha helical CRF9-41, as antagonists of CRF in in vivo and in vitro assays. In halothane-anesthetized rats, intracerebroventricular (i.c.v.) administration of both analogs inhibited the activation of locus coeruleus (LC) neuronal discharge produced by CRF (3.0 micrograms, i.c.v.). LC activation by hypotensive stress elicited by intravenous (i.v.) infusion of nitroprusside was antagonized by the same doses of the CRF antagonists that were effective in antagonizing CRF, suggesting that the receptors involved in LC activation by CRF and by hypotensive stress are similar. However, D-PheCRF12-41 was approximately 100 times more potent than alpha helical CRF9-41 when administered i.c.v. The IC50 values for D-PheCRF12-41 as an antagonist of CRF and of nitroprusside were 0.16 and 0.14 microgram, i.c.v., respectively. The IC50 values for alpha helical CRF9-41 as an antagonist of CRF and of nitroprusside were 18 and 27 micrograms, i.c.v., respectively. In contrast, D-PheCRF12-41 was only slightly more potent than alpha helical CRF9-41 in antagonizing CRF-stimulated cyclic AMP production in rat brain homogenates, with IC50s of 78 +/- 15 and 260 +/- 30 nM for D-PheCRF12-41 and alpha helical CRF9-41, respectively. Moreover, the antagonists had similar affinities for CRF binding sites in rat brain homogenates, with Kis of 15.5 +/- 4 nM and 10.3 +/- 6 nM for D-PheCRF12-41 and alpha helical CRF9-41, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A L Curtis; D E Grigoriadis; M E Page; J Rivier; R J Valentino
Related Documents :
16427077 - Functional remodeling in post-myocardial infarcted rats: focus on beta-adrenoceptor sub...
16231217 - Efficient enzymatic synthesis of 4-methylumbelliferyl n-acetyllactosaminide and 4-methy...
7043307 - Cellular localization of the brain specific alpha 2-glycoprotein in rat cerebellum: an ...
23275047 - Cognitive performance and response inhibition in developmentally vitamin d (dvd)-defici...
1129357 - Tricyclic antidepressants: effects on extinction and fear learning.
192457 - Influence of age at inoculation on avian oncornavirus-induced brain tumor incidence, tu...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  268     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1994 Jan 
Date Detail:
Created Date:  1994-03-10     Completed Date:  1994-03-10     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  359-65     Citation Subset:  IM    
Affiliation:
Department of Mental Health Science, Hahnemann University, Philadelphia, Pennsylvania.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenylate Cyclase / metabolism
Animals
Corticotropin-Releasing Hormone / analogs & derivatives*,  antagonists & inhibitors,  metabolism,  pharmacology*
Enzyme Activation
Locus Coeruleus / cytology,  drug effects
Male
Neurons / drug effects
Peptide Fragments / metabolism,  pharmacology*
Rats
Rats, Sprague-Dawley
Receptors, Corticotropin-Releasing Hormone / metabolism
Grant Support
ID/Acronym/Agency:
MH 00840/MH/NIMH NIH HHS; MH 40008/MH/NIMH NIH HHS; MH 42796/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/H-R corticotropin-releasing factor (12-41), Phe(12)-Nle(21,38), C(alpha-MeLeu(37))-; 0/Peptide Fragments; 0/Receptors, Corticotropin-Releasing Hormone; 0/phenylalanyl corticotropin-releasing factor (12-41); 9015-71-8/Corticotropin-Releasing Hormone; 96118-75-1/corticotropin releasing hormone (9-41); EC 4.6.1.1/Adenylate Cyclase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs.
Next Document:  Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive...